Web Analytics

FDA Announces Plan to Phase Out Animal Testing. Will That Work? – New Study



Human organs-on-chips and organoids offer new alternatives to animals for drug development, but there is still a long way to go.



Summary

Human organ-on-chips and organoids are emerging as promising alternatives to animal testing in drug development. These miniature, lab-grown models mimic the structure and function of human organs, offering more relevant insights into drug efficacy and toxicity. However, these technologies are still in their early stages of development and refinement. Challenges remain in replicating the complexity of whole organs and ensuring the reliability and reproducibility of results. While holding significant potential to reduce reliance on animal models, further research and validation are necessary before widespread adoption in drug development pipelines.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer

Dr AF Saeed

Related post

Thank you for Visiting. Leave a Reply!

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.